FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766703403> ?p ?o ?g. }

• W2766703403 abstract "Prior Studies have suggested better outcomes in smokers compared with nonsmokers receiving clopidogrel (smoker's paradox). The impact of a more intensive clopidogrel regimen on ischemic and bleeding risks in smokers with acute coronary syndromes requiring percutaneous coronary interventions remains unclear.We analyzed 17 263 acute coronary syndrome patients undergoing percutaneous coronary intervention from the CURRENT-OASIS 7 (Clopidogrel and Aspirin Optimal Dose Usage to Reduce Recurrent Events-Seventh Organization to Assess Strategies in Ischemic Symptoms) trial, which compared double-dose (600 mg day 1;150 mg days 2-7; then 75 mg daily) versus standard-dose (300 mg day 1; then 75 mg daily) clopidogrel in acute coronary syndrome patients. The primary outcome was cardiovascular death, myocardial infarction, or stroke at 30 days. Interactions between treatment allocation and smoking status (current smokers versus nonsmokers) were evaluated. Overall, 6394 patients (37.0%) were current smokers. For the comparison of double- versus standard-dose clopidogrel, there were significant interactions in smokers and nonsmokers for the primary outcome (P=0.031) and major bleeding (P=0.002). Double- versus standard-dose clopidogrel reduced the primary outcome among smokers by 34% (hazard ratio [HR] 0.66, 95% confidence interval [CI], 0.50-0.87, P=0.003), whereas in nonsmokers, there was no apparent benefit (HR 0.96, 95% CI, 0.80-1.14, P=0.61). For major bleeding, there was no difference between the groups in smokers (HR 0.77, 95% CI, 0.48-1.24, P=0.28), whereas in nonsmokers, the double-dose clopidogrel regimen increased bleeding (HR 1.89, 95% CI, 1.37-2.60, P<0.0001). Double-dose clopidogrel reduced the incidence of definite stent thrombosis in smokers (HR 0.41, 95% CI, 0.24-0.71) and nonsmokers (HR 0.63, 95% CI, 0.42-0.93; P for interaction=0.19).In smokers, a double-dose clopidogrel regimen reduced major cardiovascular events and stent thrombosis after percutaneous coronary intervention, with no increase in major bleeding. This suggests that clopidogrel dosing in patients with acute coronary syndromes should be personalized, taking into consideration both ischemic and bleeding risk.URL: https://www.clinicaltrials.gov. Unique identifier: NCT00335452." @default.
• W2766703403 created "2017-11-10" @default.
• W2766703403 creator A5004104973 @default.
• W2766703403 creator A5007241038 @default.
• W2766703403 creator A5009948614 @default.
• W2766703403 creator A5010148220 @default.
• W2766703403 creator A5014032885 @default.
• W2766703403 creator A5014449865 @default.
• W2766703403 creator A5015203786 @default.
• W2766703403 creator A5018419311 @default.
• W2766703403 creator A5027244910 @default.
• W2766703403 creator A5039466154 @default.
• W2766703403 creator A5040111710 @default.
• W2766703403 creator A5057167171 @default.
• W2766703403 creator A5063859581 @default.
• W2766703403 creator A5084054817 @default.
• W2766703403 date "2017-11-01" @default.
• W2766703403 modified "2023-10-02" @default.
• W2766703403 title "Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention" @default.
• W2766703403 cites W129875822 @default.
• W2766703403 cites W1975519565 @default.
• W2766703403 cites W1990864736 @default.
• W2766703403 cites W2016437276 @default.
• W2766703403 cites W2018019885 @default.
• W2766703403 cites W2018147971 @default.
• W2766703403 cites W2021969315 @default.
• W2766703403 cites W2024337163 @default.
• W2766703403 cites W2033160018 @default.
• W2766703403 cites W2046673676 @default.
• W2766703403 cites W2060560738 @default.
• W2766703403 cites W206549115 @default.
• W2766703403 cites W2090210165 @default.
• W2766703403 cites W2094333691 @default.
• W2766703403 cites W2097546384 @default.
• W2766703403 cites W2099409915 @default.
• W2766703403 cites W2105005467 @default.
• W2766703403 cites W2109577952 @default.
• W2766703403 cites W2111366812 @default.
• W2766703403 cites W2118233913 @default.
• W2766703403 cites W2120696185 @default.
• W2766703403 cites W2140808934 @default.
• W2766703403 cites W2144206796 @default.
• W2766703403 cites W2157964007 @default.
• W2766703403 cites W2170949977 @default.
• W2766703403 cites W2213141251 @default.
• W2766703403 cites W2341354309 @default.
• W2766703403 cites W2419183002 @default.
• W2766703403 cites W2515525176 @default.
• W2766703403 cites W2885555063 @default.
• W2766703403 cites W2991009371 @default.
• W2766703403 cites W36049561 @default.
• W2766703403 cites W47760588 @default.
• W2766703403 doi "https://doi.org/10.1161/jaha.117.006577" @default.
• W2766703403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5721756" @default.
• W2766703403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29101117" @default.
• W2766703403 hasPublicationYear "2017" @default.
• W2766703403 type Work @default.
• W2766703403 sameAs 2766703403 @default.
• W2766703403 citedByCount "9" @default.
• W2766703403 countsByYear W27667034032018 @default.
• W2766703403 countsByYear W27667034032019 @default.
• W2766703403 countsByYear W27667034032020 @default.
• W2766703403 countsByYear W27667034032022 @default.
• W2766703403 crossrefType "journal-article" @default.
• W2766703403 hasAuthorship W2766703403A5004104973 @default.
• W2766703403 hasAuthorship W2766703403A5007241038 @default.
• W2766703403 hasAuthorship W2766703403A5009948614 @default.
• W2766703403 hasAuthorship W2766703403A5010148220 @default.
• W2766703403 hasAuthorship W2766703403A5014032885 @default.
• W2766703403 hasAuthorship W2766703403A5014449865 @default.
• W2766703403 hasAuthorship W2766703403A5015203786 @default.
• W2766703403 hasAuthorship W2766703403A5018419311 @default.
• W2766703403 hasAuthorship W2766703403A5027244910 @default.
• W2766703403 hasAuthorship W2766703403A5039466154 @default.
• W2766703403 hasAuthorship W2766703403A5040111710 @default.
• W2766703403 hasAuthorship W2766703403A5057167171 @default.
• W2766703403 hasAuthorship W2766703403A5063859581 @default.
• W2766703403 hasAuthorship W2766703403A5084054817 @default.
• W2766703403 hasBestOaLocation W27667034031 @default.
• W2766703403 hasConcept C126322002 @default.
• W2766703403 hasConcept C164705383 @default.
• W2766703403 hasConcept C207103383 @default.
• W2766703403 hasConcept C2777628954 @default.
• W2766703403 hasConcept C2777698277 @default.
• W2766703403 hasConcept C2777849778 @default.
• W2766703403 hasConcept C2778905298 @default.
• W2766703403 hasConcept C2780400711 @default.
• W2766703403 hasConcept C2781413609 @default.
• W2766703403 hasConcept C35294091 @default.
• W2766703403 hasConcept C42219234 @default.
• W2766703403 hasConcept C44249647 @default.
• W2766703403 hasConcept C500558357 @default.
• W2766703403 hasConcept C71924100 @default.
• W2766703403 hasConceptScore W2766703403C126322002 @default.
• W2766703403 hasConceptScore W2766703403C164705383 @default.
• W2766703403 hasConceptScore W2766703403C207103383 @default.
• W2766703403 hasConceptScore W2766703403C2777628954 @default.
• W2766703403 hasConceptScore W2766703403C2777698277 @default.
• W2766703403 hasConceptScore W2766703403C2777849778 @default.
• W2766703403 hasConceptScore W2766703403C2778905298 @default.

• next